Qing Liu

Qing Liu is an Assistant Professor in the Department of Biological Sciences at Clemson University's College of Science. His research focuses on cardiovascular toxicology, metabolism, and stem cell biology. He leads the Liu laboratory, which investigates mechanisms of cardiac dysfunction due to toxicant exposure and develops human stem cell-based systems to study metabolic remodeling during cardiac differentiation.

Education:

• Postdoc in Genomics, Stanford University School of Medicine
• Ph.D., Molecular Toxicology, University of Wisconsin Milwaukee
• B.S., Biological Sciences, Nanjing University

Research Interests: The lab integrates experimental and computational biology to address knowledge gaps in cardiovascular dysfunction caused by environmental exposures. Key areas include mitochondrial dynamics, drug-induced cardiotoxicity, and SARS-CoV-2's impact on cardiomyocytes. They employ CRISPR-based genome-wide screening and 'Omics technologies.

Recent Research Trends: Publications emphasize mitochondrial dysfunction's role in drug toxicity, cancer-associated RNA regulation, and SARS-CoV-2 protein effects on cardiac metabolism. Work spans developmental toxicology, viral pathogenesis, and therapeutic mitigation strategies.

Advising & Labs: Advises PhD students, undergraduates, and postdocs. Lab alumni include researchers now in medical schools and industry. Active in teaching courses like Cell Biology and Undergraduate Research in Biological Sciences.

Labs/Teams: Liu Lab focuses on translational research bridging toxicology and cardiovascular biology, with collaborations in computational biology and personalized medicine.